Patient Pathfinder: Clinical Trials
Clinical Trials for Non Hodgkin Lymphoma
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 515 active Non Hodgkin Lymphoma trials
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Study Type: Interventional Phase 1
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Study Type: Interventional Phase 1
Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma
Study Type: Interventional Phase 1
Lifestyle Intervention of Food and Exercise for Lymphoma Survivors
Study Type: Interventional
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Study Type: Interventional Phase 1
Study of IMPT-314 in R/R Aggressive B-cell NHL
Study Type: Interventional Phase 1
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma
Study Type: Interventional Phase 1
Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
Study Type: Interventional Phase 1
There are 515 active Non Hodgkin Lymphoma trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now